Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IGHGP stands for Immunoglobulin heavy constant gamma P pseudogene. Located within the immunoglobulin heavy chain gene cluster on human chromosome 14, IGHGP is a non-functional genomic segment that resembles functional IGHG genes, which encode the constant regions of immunoglobulin gamma heavy chains (the main protein components of IgG antibodies)[1][2]. Pseudogenes like IGHGP may arise from gene duplication or retrotransposition events, leading to loss of protein-coding ability through frameshift mutations or premature stop codons. IGHGP does not encode a functional protein and does not contribute to immune system function, antibody formation, or therapeutic targeting[1][2]. It is sometimes referenced in genomic studies cataloging the full diversity of the immunoglobulin heavy chain locus but has no direct biological or clinical relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunoglobulin heavy constant gamma P pseudogene (IGHGP).